Since we did not find any differences in TIM-3 expression on CD4+ and CD8+ TILs, we focused our investigations on CD4+ T cells to study the significance of TIM-3 expression on T cells/Tregs in the CRC TME. The gene discussed is HAVCR2; the disease is colorectal carcinoma.